Robert G. Aslanian;Kevin D. McCormick;Salem Fevrier;Phieng Siliphaivanh;Henry Vaccaro;Christopher W. Boyce;Anandan Palani;Joey L. Methot;William Colby Brown
发明人:
Christopher W. Boyce,Salem Fevrier,Kevin D. McCormick,Anandan Palani,Robert G. Aslanian,Phieng Siliphaivanh,Joey L. Methot,William Colby Brown,Henry Vaccaro
申请号：
US13996371
公开号：
US20130296300A1
申请日:
2011.12.19
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention provides certain quinolines and aza-quinolines of the Formula (I), and their pharmaceutically acceptable salts, wherein E, J1, Ja, Jb, R2, R3, R22, Ra, Rb, Rc, Rd, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH2 function.
